IP Library Granted Patent US 8,182,799
Granted Patent B2
US 8,182,799 · App. 12/479,079 · Granted May 22, 2012

Treatment and composition for achieving skin anti-aging benefits by corneum protease activation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,182,799
App. No.
12/479,079
Granted
May 22, 2012
Kind
B2
Abstract

Novel methods and compositions for treating aged and environmentally damaged skin are disclosed which provide improvements in the skin's visual appearance, function and clinical/biophysical properties by activating at least one proteolytic enzyme in the skin's stratum corneum. The disclosed treatment methods involve topical application of a novel cosmetic composition containing a combination of a cationic surfactant such as N,N,-dimethyldodecyl amine oxide (DMDAO), an anionic surfactant such as sodium dodecyl sulfate (SDS), or monoalkyl phosphate (MAP) and a chelating agent such as ethylene diamine tetraacetate (EDTA) to stimulate a chronic increase in the replacement rate of the skin's stratum corneum by means of corneum protease activation. This chronic, low level stimulation is effective to induce repair and replacement of the stratum corneum, epidermis, and dermis of the skin and improvements in the appearance, function, and anti-aging properties of the skin.

Claims (16)

1. A topical skin composition comprising:

(i) a chemically compatible combination of one or more surfactants and at least one chelating agent;

(ii) at least two UV absorbing agents selected from the group consisting of avobenzone, homosalate, and benzophenone-3;

(iii) tocopheryl acetate; and

(iv) retinyl palmitate,

wherein the composition is formulated for topical application to skin.

2. The topical skin composition of claim 1 , wherein the one or more surfactants is selected from the group consisting of N,N,-dimethyldodecyl amine oxide, sodium dodecyl sulfate, or monoalkyl phosphate.

3. The topical skin composition of claim 2 , wherein the chelating agent is ethylene diamine tetraacetate (EDTA).

4. The topical skin composition of claim 2 , wherein composition is formulated as an oil-in-water emulsion.

5. A topical skin composition comprising:

(i) a chemically compatible combination of one or more surfactants and at least one chelating agent; and

(ii) a combination of UVA and UVB absorbing agents,

wherein said composition is formulated as an oil-in-water emulsion.

6. The topical skin composition of claim 5 , wherein the one or more surfactants is selected from the group consisting of N,N,-dimethyldodecyl amine oxide, sodium dodecyl sulfate, or monoalkyl phosphate.

7. The topical skin composition of claim 6 , wherein the chelating agent is ethylene diamine tetraacetate (EDTA).

8. The topical skin composition of claim 4 , wherein the composition includes at least two UV absorbing agents selected from the group consisting of avobenzone, homosalate, and benzophenone-3.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: MARY KAY INC.
To: ALLUSTRA TECHNOLOGIES LLC
Reel/Frame 061625/0039 →